Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Pedro, Pujante Alarcón"'
Autor:
Diego Rivas-Otero, Tomás González-Vidal, Pedro Pujante Alarcón, Elías Delgado Álvarez, Edelmiro Menéndez Torre
Publikováno v:
Case Reports in Endocrinology, Vol 2024 (2024)
Conclusion: Hypopituitarism should be suspected in patients with head trauma and symptoms of hormone deficiency. Advanced clinical forms, such as myxedema coma, may also occur. Pituitary hormone levels might be in the normal range, so target gland ho
Externí odkaz:
https://doaj.org/article/d029fc9145464d629178aea8b1777f76
Autor:
Pedro Pujante Alarcón, Carlos Alonso Felgueroso, Jessica Ares Blanco, Paula Morales Sánchez, Carmen Lambert Goitia, Raúl Rodríguez Escobedo, Sandra Rodríguez Rodero, Elías Delgado Alvarez, Edelmiro Luis Menéndez Torre
Publikováno v:
Endocrinología, Diabetes y Nutrición. 69:493-499
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce182e8e049c779e5d4eabf561babd77
https://doi.org/10.1016/j.endinu.2021.10.008
https://doi.org/10.1016/j.endinu.2021.10.008
Autor:
Gemma Rojo Martínez, Santiago Conde Barreiro, Elías Álvarez, Paula Morales Sánchez, Edelmiro Luis Menendez Torre, Raúl Rodríguez Escobedo, Pedro Pujante Alarcón
Publikováno v:
Medicina Clínica. 158:153-158
Resumen Introduccion y objetivos La enfermedad cardiovascular ateroesclerotica y la insuficiencia cardiaca (IC) son la principal causa de morbimortalidad en los pacientes con diabetes. El objetivo de este trabajo es conocer la prevalencia de enfermed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3633e860361e8d2f7bbc16b84e0b798b
https://doi.org/10.1016/j.medcli.2020.12.040
https://doi.org/10.1016/j.medcli.2020.12.040
Autor:
Pedro Pujante Alarcón, Edelmiro Luis Menéndez Torre, Paula Morales Sánchez, Raúl Rodríguez Escobedo, Santiago Conde Barreiro, Gemma Rojo Martínez, Elías Delgado Alvarez
Publikováno v:
Medicina Clínica (English Edition). 158:153-158
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a471ace88367c4b4819f8388103fdf71
https://doi.org/10.1016/j.medcle.2020.12.040
https://doi.org/10.1016/j.medcle.2020.12.040
Autor:
Edelmiro Menéndez-Torre, Patricia Botas Cervero, Elías Delgado Álvarez, Cecilia Sánchez-Ragnarsson, Pedro Pujante Alarcón, Sergio Valdés Hernández, Jessica Ares Blanco
Publikováno v:
Endocrinología, Diabetes y Nutrición (English ed.). 66:487-494
Introduction and objectives In epidemiological studies, excess body fat (BF) has been associated with cardiometabolic risk factors, some types of cancer, and other causes of death. A new anthropometric method has been defined: The CUN-BAE index (Univ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e115034572005d194721ade4bfcd502
https://doi.org/10.1016/j.endien.2019.02.008
https://doi.org/10.1016/j.endien.2019.02.008
Autor:
Elias Delgado, Laura Cacho, Fernando García Urruzola, Cecilia Sanchez Ragnarson, Edelmiro Luis Menendez Torre, Jessica Ares, Laura Manjón, Pedro Pujante Alarcón, Raul Rodriguez Escobedo
Publikováno v:
Endocrinología, Diabetes y Nutrición. 66:210-216
Resumen Introduccion Los tratamientos insulinicos actuales para diabetes tipo 1 (DM1) no siempre consiguen los objetivos de control metabolico debido, entre otros aspectos, a la aparicion de episodios de hipoglucemia asociados al uso de insulina. Mat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b5d76615d66b513a3c3e2be55001967
https://doi.org/10.1016/j.endinu.2018.09.006
https://doi.org/10.1016/j.endinu.2018.09.006
Autor:
Jessica Ares, Elias Delgado, Raul Rodriguez Escobedo, Laura Manjón, Cecilia Sanchez Ragnarson, Fernando García Urruzola, Pedro Pujante Alarcón, Edelmiro Luis Menendez Torre, Laura Cacho
Publikováno v:
Endocrinología, Diabetes y Nutrición (English ed.). 66:210-216
Current treatment of type 1 diabetes mellitus (T1DM) does not always achieve metabolic control because, among other things, the ocurrence of hypoglycemic events associated to insulin use.A descriptive real life study of 247 T1DM patients, 55.5% male,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5501e45513cb2d8fc9aa330714d841c
https://doi.org/10.1016/j.endien.2018.09.002
https://doi.org/10.1016/j.endien.2018.09.002
Autor:
Pedro Pujante Alarcón, Carlos Alonso Felgueroso, Jessica Ares Blanco, Paula Morales Sánchez, Carmen Lambert Goitia, Raúl Rodríguez Escobedo, Sandra Rodríguez Rodero, Elías Delgado Alvarez, Edelmiro Luis Menéndez Torre
Publikováno v:
Endocrinologia, diabetes y nutricion. 69(7)
Despite continuous glucose monitoring having been proven useful in patients with type 1 diabetes mellitus, A1C remains the gold standard for assessing disease management.Descriptive, retrospective study which included 252 patients, 40.5% male, mean a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce6eab9426f98e302dea8d3c31211f7d
https://pubmed.ncbi.nlm.nih.gov/36028448
https://pubmed.ncbi.nlm.nih.gov/36028448
Autor:
Pedro, Pujante Alarcón, Edelmiro Luis, Menéndez Torre, Paula, Morales Sánchez, Raúl, Rodríguez Escobedo, Santiago, Conde Barreiro, Gemma, Rojo Martínez, Elías, Delgado Alvarez
Publikováno v:
Medicina clinica. 158(4)
Atherosclerotic cardiovascular disease and heart failure are the leading cause of morbidity and mortality in patients with diabetes. The objective of this work is to know the prevalence of atherosclerotic cardiovascular diseases and heart failure in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d02af9575ad5a7f11dbb2fba3688261e
https://pubmed.ncbi.nlm.nih.gov/33810870
https://pubmed.ncbi.nlm.nih.gov/33810870
Autor:
María Dolores Hellín Gil, Pedro Pujante Alarcón, Alicia Hernández Torres, María Ángeles Ibáñez Gil, Ana Belén Hernández Cascales, Alfonso López Ruiz
Publikováno v:
Pharmacology & Pharmacy. :149-152
Worldwide, the prevalence of diabetes and obesity is increasing in recent years in developed countries. The first step of treatment is changes in lifestyle and in case of failure to initiate drug treatment. In our case, the patient with morbid obesit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73305c0851ed74ef03cd88b06ca6f2b6
https://doi.org/10.4236/pp.2014.52020
https://doi.org/10.4236/pp.2014.52020